An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Previously reported prognostic signatures for predicting the prognoses of postsurgical hepatocellular carcinoma (HCC) patients are commonly based on predefined risk scores, which are hardly applicable to samples measured by different laboratories. To solve this problem, using gene expression profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Lu, Song, Xuekun, Li, Xiangyu, Tong, Mengsha, Guo, You, Li, Jing, Li, Hongdong, Cai, Hao, Li, Mengyao, Guan, Qingzhou, Yan, Haidan, Guo, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029687/
https://www.ncbi.nlm.nih.gov/pubmed/27006471
http://dx.doi.org/10.18632/oncotarget.8212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029687/
https://www.ncbi.nlm.nih.gov/pubmed/27006471
http://dx.doi.org/10.18632/oncotarget.8212

Ejemplares similares